Ozempic and Ibuprofen / NSAIDs
There is no prominent direct Ozempic–ibuprofen pharmacokinetic interaction in labelling. The concern is additive kidney and gastrointestinal risk, especially if semaglutide causes vomiting, diarrhea, or reduced fluid intake and you use NSAIDs while dehydrated.
There is no prominent direct Ozempic–ibuprofen pharmacokinetic interaction in labelling. The concern is additive kidney and gastrointestinal risk, especially if semaglutide causes vomiting, diarrhea, or reduced fluid intake and you use NSAIDs while dehydrated.
Key Takeaways
- There is no direct interaction between Ozempic and ibuprofen in labelling.
- The real risk is additive kidney injury when NSAIDs are taken during dehydration from GI side effects.
- Risk is low for occasional NSAID use in low-risk patients, higher in kidney disease, older age, or with diuretics/ACE inhibitors/ARBs.
- Avoid NSAIDs during vomiting, diarrhea, or poor fluid intake unless a clinician advises otherwise.
- Ask about acetaminophen or topical options if appropriate for pain.
Ozempic and Ibuprofen at a Glance
| Property | Detail |
|---|---|
| Drugs involved | Semaglutide (Ozempic) + NSAIDs (ibuprofen, naproxen, etc.) |
| Interaction type | No direct PK interaction; additive kidney and GI risk |
| Overall risk | Low for short occasional use in low-risk patients; moderate to serious if dehydrated or CKD |
| Highest-risk groups | CKD, older age, diuretic/ACE-inhibitor/ARB use, persistent vomiting/diarrhea |
| Key action | Avoid NSAIDs during GI illness or dehydration; ask about safer pain options |
How They Interact
Semaglutide can cause GI fluid loss and dehydration; NSAIDs can reduce the kidney's blood-flow protection, particularly during dehydration. Ozempic labelling warns of acute kidney injury due to volume depletion, and kidney organisations identify NSAID kidney risk, particularly in dehydration and chronic kidney disease.
Reaching for ibuprofen while on Ozempic?
Check semaglutide and NSAIDs against your full medication list, including kidney-risk medicines. Allmeds flags the risk in minutes.
Interaction Profile in Detail
| Dimension | Research summary |
|---|---|
| Mechanism | Semaglutide can cause GI fluid loss and dehydration; NSAIDs can reduce kidney blood-flow protection, particularly during dehydration. |
| Clinical evidence | Ozempic labelling warns of acute kidney injury due to volume depletion. NIDDK and kidney organisations identify NSAID kidney risk, particularly in dehydration and CKD. |
| Severity | Low for short-term occasional NSAID use in low-risk patients; moderate to serious in CKD, dehydration, older age, diuretic/ACE-inhibitor/ARB use, or persistent vomiting/diarrhea. |
| Symptoms to watch | Reduced urination, swelling, dizziness, severe stomach pain, black stools, persistent vomiting, or worsening kidney labs. |
| Official guidance | Ozempic label warns about kidney injury from GI fluid losses. Kidney guidance recommends avoiding or minimising NSAIDs in CKD and dehydration. |
| Practical patient advice | Avoid NSAIDs during vomiting, diarrhea, or poor fluid intake unless a clinician advises otherwise. Ask about acetaminophen or topical options if appropriate. |
Symptoms to Watch & When to Seek Care
| Symptom or Sign | What It May Indicate | Action |
|---|---|---|
| Reduced urination, swelling, severe dizziness | Possible acute kidney injury | Stop NSAID; seek medical assessment |
| Black or tarry stools, severe stomach pain | Possible GI bleeding/ulcer | Seek urgent care |
| Taking NSAIDs during vomiting/diarrhea | Higher kidney-injury risk when dehydrated | Avoid NSAIDs; hydrate; ask about alternatives |
| On diuretics, ACE inhibitors, or ARBs | Added kidney risk with NSAIDs | Ask a pharmacist before using NSAIDs |
Common Questions About Ozempic and Ibuprofen
Many low-risk patients may use occasional ibuprofen, but ask a clinician if you have kidney disease or dehydration.
Dehydration plus NSAIDs can reduce kidney filtration and increase acute-kidney-injury risk.
Not generally banned, but risk-based caution is important.
Acetaminophen may be safer for kidneys at recommended doses, but liver disease and other risks must be considered.
Avoid self-use during vomiting, diarrhea, poor fluid intake, CKD, heart failure, or certain blood-pressure-medicine combinations unless advised.
Check Ozempic against your full medication list
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile, in minutes.
References
- U.S. Food & Drug Administration. Ozempic (semaglutide) prescribing information. fda.gov.
- U.S. Food & Drug Administration. Wegovy (semaglutide) prescribing information. fda.gov.
- U.S. Food & Drug Administration. Mounjaro (tirzepatide) prescribing information. fda.gov.
- European Medicines Agency. Ozempic / Wegovy / Mounjaro EPAR product information. ema.europa.eu.
- Therapeutic Goods Administration (Australia). Australian Register of Therapeutic Goods (ARTG). tga.gov.au.